These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3571122)

  • 1. General Referee reports: Committee on Drugs and Related Topics.
    J Assoc Off Anal Chem; 1987; 70(2):268-70. PubMed ID: 3571122
    [No Abstract]   [Full Text] [Related]  

  • 2. [Control of drugs in foreign countries].
    Buriánek J; Parrák V
    Cesk Farm; 1973 Jul; 22(6):247-53. PubMed ID: 4732551
    [No Abstract]   [Full Text] [Related]  

  • 3. Adulteration of drugs and foods: compendial approaches to lowering risk.
    Abernethy DR; Sheehan C; Griffiths JC; Williams RL;
    Clin Pharmacol Ther; 2009 Apr; 85(4):444-7. PubMed ID: 18463621
    [No Abstract]   [Full Text] [Related]  

  • 4. Keeping watch on drug quality.
    Furman WB
    FDA Consum; 1975 Oct; 9(8):18-23. PubMed ID: 10316632
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmaceutical analysis: key to drug quality and control.
    Florey KG; Brewer GA
    Am Pharm; 1981 Aug; NS21(8):30-5. PubMed ID: 7270421
    [No Abstract]   [Full Text] [Related]  

  • 6. Assuring total drug quality.
    Simmons HE
    J Am Pharm Assoc; 1973 Feb; 13(2):96-8. PubMed ID: 4686621
    [No Abstract]   [Full Text] [Related]  

  • 7. Standardization of forensic drug analyses.
    Frank RS; Gunn JW
    J Forensic Sci; 1974 Jan; 19(1):163-7. PubMed ID: 4854386
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of regulatory agencies and industry in assessment of the safety of drugs for use in man. United States Food and Drug Administration's viewpoint.
    Ley HL; Desmond FH
    Can Med Assoc J; 1968 Feb; 98(6):318-21. PubMed ID: 5636100
    [No Abstract]   [Full Text] [Related]  

  • 9. How good are our drugs?
    Miller LC
    Am J Hosp Pharm; 1970 May; 27(5):367-74. PubMed ID: 5422276
    [No Abstract]   [Full Text] [Related]  

  • 10. Report on the PQRI impurity characterization and quantification best practices survey.
    Faustino P; Chan CC; Carrano J; Gosnell M; Gu ZQ; Maule A; Sigvardson K; Zhang YF
    Pharm Res; 2006 Feb; 23(2):440-6. PubMed ID: 16477396
    [No Abstract]   [Full Text] [Related]  

  • 11. New classification of drugs.
    J Fla Med Assoc; 1972 Jan; 59(1):37. PubMed ID: 5058956
    [No Abstract]   [Full Text] [Related]  

  • 12. New drugs.
    Hussar DA
    Nursing; 1992 May; 22(5):55-61. PubMed ID: 1584496
    [No Abstract]   [Full Text] [Related]  

  • 13. Controlling the quality of Uncle Sam's drugs.
    Hecht A
    FDA Consum; 1977 May; 11(4):22-3. PubMed ID: 10316531
    [No Abstract]   [Full Text] [Related]  

  • 14. F.D.A. to assess O.T.C. drugs for safety, efficacy, labeling.
    Bowles GC
    Mod Hosp; 1972 Mar; 118(3):126. PubMed ID: 5058060
    [No Abstract]   [Full Text] [Related]  

  • 15. Update on counterfeit drugs.
    FDA Consum; 2005; 39(5):6-7. PubMed ID: 16419283
    [No Abstract]   [Full Text] [Related]  

  • 16. Bulk drugs and chemical substances.
    Gushee J
    J Am Vet Med Assoc; 1986 Oct; 189(8):878-9. PubMed ID: 3771357
    [No Abstract]   [Full Text] [Related]  

  • 17. Curbing counterfeit drugs.
    FDA Consum; 2006; 40(5):11. PubMed ID: 17326307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assuring the quality of the nation's drugs. Interview by William E. Small.
    Michels D
    Am Pharm; 1980 Apr; NS20(4):40-2. PubMed ID: 7386377
    [No Abstract]   [Full Text] [Related]  

  • 19. The Food and Drug Administration's over-the-counter drug review: why review OTC drugs?
    Moxley JH; Yingling GL; Edwards CC
    Fed Proc; 1973 Apr; 32(4):1435-7. PubMed ID: 4701750
    [No Abstract]   [Full Text] [Related]  

  • 20. General Referee reports: Committee on Feeds, Fertilizers, and Related Materials.
    J Assoc Off Anal Chem; 1987; 70(2):309-14. PubMed ID: 3032892
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.